Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1968 1
1970 1
1971 2
1972 4
1973 6
1974 7
1975 6
1976 8
1977 3
1978 3
1979 4
1980 7
1981 5
1982 3
1983 3
1984 2
1985 6
1986 3
1987 2
1988 3
1989 4
1990 4
1991 2
1992 2
1993 4
1994 2
1995 4
1996 6
1997 4
1998 5
1999 3
2000 1
2001 3
2002 3
2003 2
2005 3
2006 5
2007 3
2008 5
2009 6
2010 6
2011 8
2012 6
2013 6
2014 7
2015 7
2016 5
2017 5
2018 3
2019 1
2020 6
2021 6
2022 6
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Pant S, Schuler M, Iyer G, Witt O, Doi T, Qin S, Tabernero J, Reardon DA, Massard C, Minchom A, Lugowska I, Carranza O, Arnold D, Gutierrez M, Winter H, Stuyckens K, Crow L, Najmi S, Hammond C, Thomas S, Santiago-Walker A, Triantos S, Sweiti H, Loriot Y; RAGNAR Investigators. Pant S, et al. Lancet Oncol. 2023 Aug;24(8):925-935. doi: 10.1016/S1470-2045(23)00275-9. Lancet Oncol. 2023. PMID: 37541273 Clinical Trial.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Understanding shoulder pseudoparalysis. Part II: Treatment.
Coward JC, Bauer S, Babic SM, Coron C, Okamoto T, Blakeney WG. Coward JC, et al. EFORT Open Rev. 2022 Mar 17;7(3):227-239. doi: 10.1530/EOR-21-0070. EFORT Open Rev. 2022. PMID: 35298409 Free PMC article. Review.
Mucinous ovarian cancer: A therapeutic review.
Xu W, Rush J, Rickett K, Coward JI. Xu W, et al. Among authors: coward ji. Crit Rev Oncol Hematol. 2016 Jun;102:26-36. doi: 10.1016/j.critrevonc.2016.03.015. Epub 2016 Mar 19. Crit Rev Oncol Hematol. 2016. PMID: 27083591 Review.
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.
DeVries AA, Dennis J, Tyrer JP, Peng PC, Coetzee SG, Reyes AL, Plummer JT, Davis BD, Chen SS, Dezem FS, Aben KKH, Anton-Culver H, Antonenkova NN, Beckmann MW, Beeghly-Fadiel A, Berchuck A, Bogdanova NV, Bogdanova-Markov N, Brenton JD, Butzow R, Campbell I, Chang-Claude J, Chenevix-Trench G, Cook LS, DeFazio A, Doherty JA, Dörk T, Eccles DM, Eliassen AH, Fasching PA, Fortner RT, Giles GG, Goode EL, Goodman MT, Gronwald J; OPAL Study Group; AOCS Group; Håkansson N, Hildebrandt MAT, Huff C, Huntsman DG, Jensen A, Kar S, Karlan BY, Khusnutdinova EK, Kiemeney LA, Kjaer SK, Kupryjanczyk J, Labrie M, Lambrechts D, Le ND, Lubiński J, May T, Menon U, Milne RL, Modugno F, Monteiro AN, Moysich KB, Odunsi K, Olsson H, Pearce CL, Pejovic T, Ramus SJ, Riboli E, Riggan MJ, Romieu I, Sandler DP, Schildkraut JM, Setiawan VW, Sieh W, Song H, Sutphen R, Terry KL, Thompson PJ, Titus L, Tworoger SS, Van Nieuwenhuysen E, Edwards DV, Webb PM, Wentzensen N, Whittemore AS, Wolk A, Wu AH, Ziogas A, Freedman ML, Lawrenson K, Pharoah PDP, Easton DF, Gayther SA, Jones MR. DeVries AA, et al. J Natl Cancer Inst. 2022 Nov 14;114(11):1533-1544. doi: 10.1093/jnci/djac160. J Natl Cancer Inst. 2022. PMID: 36210504 Free PMC article.
Chemotherapy advances in small-cell lung cancer.
Chan BA, Coward JI. Chan BA, et al. Among authors: coward ji. J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S565-78. doi: 10.3978/j.issn.2072-1439.2013.07.43. J Thorac Dis. 2013. PMID: 24163749 Free PMC article. Review.
Interleukin-6: an angiogenic target in solid tumours.
Middleton K, Jones J, Lwin Z, Coward JI. Middleton K, et al. Among authors: coward ji. Crit Rev Oncol Hematol. 2014 Jan;89(1):129-39. doi: 10.1016/j.critrevonc.2013.08.004. Epub 2013 Aug 28. Crit Rev Oncol Hematol. 2014. PMID: 24029605 Review.
The role of interleukin-6 in gynaecological malignancies.
Coward JI, Kulbe H. Coward JI, et al. Cytokine Growth Factor Rev. 2012 Dec;23(6):333-42. doi: 10.1016/j.cytogfr.2012.08.005. Epub 2012 Sep 30. Cytokine Growth Factor Rev. 2012. PMID: 23031497 Review.
220 results